Charles River Laboratories International, Inc.
CRL- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001100682
In the last 90 days, Charles River Laboratories International, Inc. insiders filed 1 open-market purchase and 9 sales; 569 institutions reported holding it in 13F filings for Q2 2026, worth $12.9B in total; Harris Associates (Oakmark) is the only superinvestor holding it.
Q4 2025 vs. Q3 2025
How the institutions holding Charles River Laboratories International, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 556 | 9 | 584 | +37 |
| Shares | 50.4M | 296.7K | 52.9M | +2.75M (+5.5%) |
| Value | $7.92B | $48.3M | $10.6B | +$2.69B (+34.2%) |
9 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (118)
Institutions that held Charles River Laboratories International, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Showing the largest 100 of 118 by value.
Sold out (81)
Institutions that held Charles River Laboratories International, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
Not filed for Q4 2025 yet (9)
Institutions that held Charles River Laboratories International, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Burgundy Asset Management Ltd. | 278,329 | $45.5M |
| AXA Investment Managers S.A. | 7,039 | $1.10M |
| CIBC Bancorp USA Inc. | 5,025 | $786.2K |
| Glenmede Investment Management, LP | 2,606 | $407.7K |
| Amica Retiree Medical Trust | 2,007 | $314.0K |
| Wetherby Asset Management Inc | 1,517 | $237.3K |
| Hemington Wealth Management | 111 | $17.0K |
| Texas Capital Bancshares Inc | 15 | $2.35K |
| Binnacle Investments Inc | 2 | $313 |